Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival.

Morin O, Chen WC, Nassiri F, Susko M, Magill ST, Vasudevan HN, Wu A, Vallières M, Gennatas ED, Valdes G, Pekmezci M, Alcaide-Leon P, Choudhury A, Interian Y, Mortezavi S, Turgutlu K, Bush NAO, Solberg TD, Braunstein SE, Sneed PK, Perry A, Zadeh G, McDermott MW, Villanueva-Meyer JE, Raleigh DR.

Neurooncol Adv. 2019 May-Dec;1(1):vdz011. doi: 10.1093/noajnl/vdz011. Epub 2019 Aug 28.

2.

Long-term outcomes of transsphenoidal surgery for management of growth hormone-secreting adenomas: single-center results.

Asha MJ, Takami H, Velasquez C, Oswari S, Almeida JP, Zadeh G, Gentili F.

J Neurosurg. 2019 Oct 11:1-11. doi: 10.3171/2019.6.JNS191187. [Epub ahead of print]

PMID:
31604330
3.

Recurrent Undifferentiated Carcinoma of the Sella in a Patient with Lynch Syndrome.

Voisin MR, Almeida JP, Perez-Ordonez B, Zadeh G.

World Neurosurg. 2019 Sep 3;132:219-222. doi: 10.1016/j.wneu.2019.08.180. [Epub ahead of print]

PMID:
31491579
4.

Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells.

Velásquez C, Mansouri S, Mora C, Nassiri F, Suppiah S, Martino J, Zadeh G, Fernández-Luna JL.

J Oncol. 2019 Jul 29;2019:1740763. doi: 10.1155/2019/1740763. eCollection 2019. Review.

5.

Evidence of small-fiber neuropathy in neurofibromatosis type 1.

Barnett C, Alon T, Abraham A, Kim RH, McCuaig JM, Kongkham P, Maurice C, Suppiah S, Zadeh G, Bril V.

Muscle Nerve. 2019 Aug 29. doi: 10.1002/mus.26687. [Epub ahead of print]

PMID:
31465118
6.

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program.

Janin M, Ortiz-Barahona V, de Moura MC, Martínez-Cardús A, Llinàs-Arias P, Soler M, Nachmani D, Pelletier J, Schumann U, Calleja-Cervantes ME, Moran S, Guil S, Bueno-Costa A, Piñeyro D, Perez-Salvia M, Rosselló-Tortella M, Piqué L, Bech-Serra JJ, De La Torre C, Vidal A, Martínez-Iniesta M, Martín-Tejera JF, Villanueva A, Arias A, Cuartas I, Aransay AM, La Madrid AM, Carcaboso AM, Santa-Maria V, Mora J, Fernandez AF, Fraga MF, Aldecoa I, Pedrosa L, Graus F, Vidal N, Martínez-Soler F, Tortosa A, Carrato C, Balañá C, Boudreau MW, Hergenrother PJ, Kötter P, Entian KD, Hench J, Frank S, Mansouri S, Zadeh G, Dans PD, Orozco M, Thomas G, Blanco S, Seoane J, Preiss T, Pandolfi PP, Esteller M.

Acta Neuropathol. 2019 Aug 19. doi: 10.1007/s00401-019-02062-4. [Epub ahead of print]

PMID:
31428936
7.

Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from two pituitary centers.

Almeida JP, Stephens CC, Eschbacher JM, Felicella MM, Yuen KCJ, White WL, Mooney MA, Bernat AL, Mete O, Zadeh G, Gentili F, Little AS.

Pituitary. 2019 Oct;22(5):514-519. doi: 10.1007/s11102-019-00981-9.

PMID:
31401793
8.

Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.

Salama Y, Albanyan S, Szybowska M, Bullivant G, Gallinger B, Giles RH, Asa S, Badduke C, Chiorean A, Druker H, Ezzat S, Hannah-Shmouni F, Hernandez KG, Inglese C, Jani P, Kaur Y, Krema H, Krimus L, Laperriere N, Lichner Z, Mete O, Sit M, Zadeh G, Jewett MAS, Malkin D, Stockley T, Wasserman JD, Xu W, Schachter NF, Kim RH.

Clin Genet. 2019 Nov;96(5):461-467. doi: 10.1111/cge.13613. Epub 2019 Aug 6.

PMID:
31368132
9.

Pituitary Apoplexy: Results of Surgical and Conservative Management Clinical Series and Review of the Literature.

Almeida JP, Sanchez MM, Karekezi C, Warsi N, Fernández-Gajardo R, Panwar J, Mansouri A, Suppiah S, Nassiri F, Nejad R, Kucharczyk W, Ridout R, Joaquim AF, Gentili F, Zadeh G.

World Neurosurg. 2019 Oct;130:e988-e999. doi: 10.1016/j.wneu.2019.07.055. Epub 2019 Jul 11.

PMID:
31302273
10.

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.

Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Ng HK, Noushmehr H, Harter P, Baumgarten P, Weller M, Preusser M, Herold-Mende C, Tatagiba M, Tabatabai G, Sahm F, von Deimling A, Zadeh G, Aldape KD; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jun 3. pii: noz061. doi: 10.1093/neuonc/noz061. [Epub ahead of print]

PMID:
31158293
11.

Needle in a Haystack: Identifying Drivers of Malignant Transformation in Neurofibromas.

Suppiah S, Aldape K, Zadeh G.

Neuro Oncol. 2019 May 16. pii: noz086. doi: 10.1093/neuonc/noz086. [Epub ahead of print] No abstract available.

PMID:
31099395
12.

A dural-based spindle cell neoplasm characterized by a novel MN1-KMT2A fusion gene.

Chen S, Dickson BC, Mohammed S, Aldape K, Swanson D, Coulombe J, Zakhari N, Karimi S, Nassiri F, Zadeh G, Mamatjan Y, Wang T, Lo B, Woulfe J.

Neuro Oncol. 2019 May 16. pii: noz091. doi: 10.1093/neuonc/noz091. [Epub ahead of print] No abstract available.

PMID:
31095693
13.

Proteomic analysis of meningiomas reveals clinically-distinct molecular patterns.

Papaioannou MD, Djuric U, Kao J, Karimi S, Zadeh G, Aldape K, Diamandis P.

Neuro Oncol. 2019 May 11. pii: noz084. doi: 10.1093/neuonc/noz084. [Epub ahead of print]

PMID:
31077268
14.

DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.

Lee DD, Leão R, Komosa M, Gallo M, Zhang CH, Lipman T, Remke M, Heidari A, Nunes NM, Apolónio JD, Price AJ, De Mello RA, Dias JS, Huntsman D, Hermanns T, Wild PJ, Vanner R, Zadeh G, Karamchandani J, Das S, Taylor MD, Hawkins CE, Wasserman JD, Figueiredo A, Hamilton RJ, Minden MD, Wani K, Diplas B, Yan H, Aldape K, Akbari MR, Danesh A, Pugh TJ, Dirks PB, Castelo-Branco P, Tabori U.

J Clin Invest. 2019 Apr 1;129(4):1801. doi: 10.1172/JCI128527. Epub 2019 Apr 1. No abstract available.

15.

Tissue 2-Hydroxyglutarate as a Biomarker for Isocitrate Dehydrogenase Mutations in Gliomas.

Sim HW, Nejad R, Zhang W, Nassiri F, Mason W, Aldape KD, Zadeh G, Chen EX.

Clin Cancer Res. 2019 Jun 1;25(11):3366-3373. doi: 10.1158/1078-0432.CCR-18-3205. Epub 2019 Feb 18.

PMID:
30777876
16.

Expanded Endonasal Endoscopic Surgery in Suprasellar Craniopharyngiomas: A Retrospective Analysis of 43 Surgeries Including Recurrent Cases.

Radovanovic I, Dehdashti AR, Turel MK, Almeida JP, Godoy BL, Doglietto F, Vescan AD, Zadeh G, Gentili F.

Oper Neurosurg (Hagerstown). 2019 Aug 1;17(2):132-142. doi: 10.1093/ons/opy356.

PMID:
30768130
17.

CIC protein instability contributes to tumorigenesis in glioblastoma.

Bunda S, Heir P, Metcalf J, Li ASC, Agnihotri S, Pusch S, Yasin M, Li M, Burrell K, Mansouri S, Singh O, Wilson M, Alamsahebpour A, Nejad R, Choi B, Kim D, von Deimling A, Zadeh G, Aldape K.

Nat Commun. 2019 Feb 8;10(1):661. doi: 10.1038/s41467-018-08087-9.

18.

Imaging and diagnostic advances for intracranial meningiomas.

Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougère C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G, Dunn IF; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i44-i61. doi: 10.1093/neuonc/noy143.

19.

Molecular and translational advances in meningiomas.

Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H, Perry A, Sahm F, Sloan A, Von Deimling A, Wen PY, Aldape K, Zadeh G; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i4-i17. doi: 10.1093/neuonc/noy178.

20.

Advances in multidisciplinary therapy for meningiomas.

Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i18-i31. doi: 10.1093/neuonc/noy136.

21.

Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life.

Nassiri F, Price B, Shehab A, Au K, Cusimano MD, Jenkinson MD, Jungk C, Mansouri A, Santarius T, Suppiah S, Teng KX, Toor GS, Zadeh G, Walbert T, Drummond KJ; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i32-i43. doi: 10.1093/neuonc/noy152.

PMID:
30649488
22.

Challenges and opportunities in meningiomas: recommendations from the International Consortium on Meningiomas.

Nassiri F, Tabatabai G, Aldape K, Zadeh G.

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i2-i3. doi: 10.1093/neuonc/noy181. No abstract available.

PMID:
30649487
23.

Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.

Mansouri A, Moraes FY, Zadeh G.

N Engl J Med. 2018 Nov 29;379(22):2177-8. doi: 10.1056/NEJMc1812500. No abstract available.

PMID:
30499640
24.

DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.

Lee DD, Leão R, Komosa M, Gallo M, Zhang CH, Lipman T, Remke M, Heidari A, Nunes NM, Apolónio JD, Price AJ, De Mello RA, Dias JS, Huntsman D, Hermanns T, Wild PJ, Vanner R, Zadeh G, Karamchandani J, Das S, Taylor MD, Hawkins CE, Wasserman JD, Figueiredo A, Hamilton RJ, Minden MD, Wani K, Diplas B, Yan H, Aldape K, Akbari MR, Danesh A, Pugh TJ, Dirks PB, Castelo-Branco P, Tabori U.

J Clin Invest. 2019 Jan 2;129(1):223-229. doi: 10.1172/JCI121303. Epub 2018 Dec 3. Erratum in: J Clin Invest. 2019 Apr 1;129(4):1801.

25.

Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?

Chiocca EA, Nassiri F, Wang J, Peruzzi P, Zadeh G.

Neuro Oncol. 2019 Jan 1;21(1):14-25. doi: 10.1093/neuonc/noy170.

PMID:
30346600
26.

Endoscopic management of Esthesioneuroblastoma: Our experience and review of the literature.

Klironomos G, Gonen L, Au K, Monteiro E, Mansouri A, Turel MK, Witterick I, Vescan A, Zadeh G, Gentili F.

J Clin Neurosci. 2018 Dec;58:117-123. doi: 10.1016/j.jocn.2018.09.011. Epub 2018 Oct 16. Review.

PMID:
30340976
27.

Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells.

Agnihotri S, Mansouri S, Burrell K, Li M, Mamatjan Y, Liu J, Nejad R, Kumar S, Jalali S, Singh SK, Vartanian A, Chen EX, Karimi S, Singh O, Bunda S, Mansouri A, Aldape KD, Zadeh G.

Clin Cancer Res. 2019 Jan 15;25(2):844-855. doi: 10.1158/1078-0432.CCR-18-1854. Epub 2018 Oct 15.

PMID:
30322879
28.

Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose.

Moraes FY, Winter J, Atenafu EG, Dasgupta A, Raziee H, Coolens C, Millar BA, Laperriere N, Patel M, Bernstein M, Kongkham P, Zadeh G, Conrad T, Chung C, Berlin A, Shultz DB.

Neuro Oncol. 2019 Feb 14;21(2):242-251. doi: 10.1093/neuonc/noy159.

PMID:
30265328
29.

Integrating Genomics Into Neuro-Oncology Clinical Trials and Practice.

Galanis E, Nassiri F, Coy S, Nejad R, Zadeh G, Santagata S.

Am Soc Clin Oncol Educ Book. 2018 May 23;38:148-157. doi: 10.1200/EDBK_200989. Review.

PMID:
30231374
30.

Impact of Dural Resection on Sinonasal Malignancies with Skull Base Encroachment or Erosion.

Ziai H, Yu E, Fu T, Muhanna N, Monteiro E, Vescan A, Zadeh G, Witterick IJ, Goldstein DP, Gentili F, de Almeida JR.

J Neurol Surg B Skull Base. 2018 Oct;79(5):419-426. doi: 10.1055/s-0037-1612617. Epub 2017 Dec 29.

31.

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges.

Mansouri A, Hachem LD, Mansouri S, Nassiri F, Laperriere NJ, Xia D, Lindeman NI, Wen PY, Chakravarti A, Mehta MP, Hegi ME, Stupp R, Aldape KD, Zadeh G.

Neuro Oncol. 2019 Feb 14;21(2):167-178. doi: 10.1093/neuonc/noy132.

PMID:
30189035
32.

Dendritic cell vaccines for high-grade gliomas.

Eagles ME, Nassiri F, Badhiwala JH, Suppiah S, Almenawer SA, Zadeh G, Aldape KD.

Ther Clin Risk Manag. 2018 Jul 26;14:1299-1313. doi: 10.2147/TCRM.S135865. eCollection 2018. Review.

33.

Recurrence of Anterior Skull Base Meningiomas After Endoscopic Endonasal Resection: 10 Years' Experience in a Series of 52 Endoscopic and Transcranial Cases.

Bernat AL, Priola SM, Elsawy A, Farrash F, Pasarikovski CR, Almeida JP, Lenck S, De Almeida J, Vescan A, Monteiro E, Zadeh GM, Gentili F.

World Neurosurg. 2018 Dec;120:e107-e113. doi: 10.1016/j.wneu.2018.07.210. Epub 2018 Aug 2.

PMID:
30077030
34.

Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care.

Djuric U, Zadeh G, Aldape K, Diamandis P.

NPJ Precis Oncol. 2017 Jun 19;1(1):22. doi: 10.1038/s41698-017-0022-1. eCollection 2017. No abstract available.

35.

The multiforme of glioblastoma.

Nassiri F, Aldape K, Zadeh G.

Neuro Oncol. 2018 Mar 27;20(4):437-438. doi: 10.1093/neuonc/noy025. No abstract available.

36.

Ethmoid Meningoencephalocele in a Patient with Cerebrofacial Arteriovenous Metameric Syndrome.

Fernández-Gajardo R, Almeida JP, Suppiah S, Witterick I, Zadeh G.

World Neurosurg. 2018 Jun;114:1-3. doi: 10.1016/j.wneu.2018.02.133. Epub 2018 Mar 3.

PMID:
29510289
37.

Extended Endoscopic Approach for Resection of Craniopharyngiomas.

Almeida JP, Suppiah S, Karekezi C, Marigil-Sanchez M, Wong JS, Vescan A, Gentili F, Zadeh G.

J Neurol Surg B Skull Base. 2018 Feb;79(2):S201-S202. doi: 10.1055/s-0037-1620244. Epub 2018 Jan 16.

38.

Quantitative comparison of cranial approaches in the anatomy laboratory: A neuronavigation based research method.

Doglietto F, Qiu J, Ravichandiran M, Radovanovic I, Belotti F, Agur A, Zadeh G, Fontanella MM, Kucharczyk W, Gentili F.

World J Methodol. 2017 Dec 26;7(4):139-147. doi: 10.5662/wjm.v7.i4.139. eCollection 2017 Dec 26.

39.

Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.

Nikolaev SI, Vetiska S, Bonilla X, Boudreau E, Jauhiainen S, Rezai Jahromi B, Khyzha N, DiStefano PV, Suutarinen S, Kiehl TR, Mendes Pereira V, Herman AM, Krings T, Andrade-Barazarte H, Tung T, Valiante T, Zadeh G, Tymianski M, Rauramaa T, Ylä-Herttuala S, Wythe JD, Antonarakis SE, Frösen J, Fish JE, Radovanovic I.

N Engl J Med. 2018 Jan 18;378(3):250-261. doi: 10.1056/NEJMoa1709449. Epub 2018 Jan 3.

40.

Management and Outcomes in the Oldest-Old Population with Glioblastoma.

Moraes FY, Lo A, Morgan ER, Millar BA, Shultz DB, Maurice C, Harlos C, Kongkham P, Bernstein M, Zadeh G, Laperriere N, Mason W, Berlin A.

Can J Neurol Sci. 2018 Mar;45(2):199-205. doi: 10.1017/cjn.2017.278. Epub 2017 Dec 18.

PMID:
29249210
41.

Glut3 Addiction: A Druggable Vulnerability in Glioblastoma.

Bunda S, Zadeh G, Aldape KD.

Cancer Cell. 2017 Dec 11;32(6):726-727. doi: 10.1016/j.ccell.2017.11.017.

42.

IDH mutation testing in gliomas-where do we draw the line?

Nassiri F, Zadeh G, Aldape K.

Neuro Oncol. 2017 Nov 29;19(12):1568-1569. doi: 10.1093/neuonc/nox164. No abstract available.

43.

Costs and Perioperative Outcomes Associated with Open versus Endoscopic Resection of Sinonasal Malignancies with Skull Base Involvement.

Fu TS, Monteiro E, Witterick I, Vescan A, Zadeh G, Gentili F, de Almeida JR.

J Neurol Surg B Skull Base. 2017 Oct;78(5):430-440. doi: 10.1055/s-0037-1603907. Epub 2017 Jun 30.

44.

Molecular Signatures for Tumor Classification: An Analysis of The Cancer Genome Atlas Data.

Mamatjan Y, Agnihotri S, Goldenberg A, Tonge P, Mansouri S, Zadeh G, Aldape K.

J Mol Diagn. 2017 Nov;19(6):881-891. doi: 10.1016/j.jmoldx.2017.07.008. Epub 2017 Sep 1.

PMID:
28867603
45.

Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram.

Ayala-Peacock DN, Attia A, Braunstein SE, Ahluwalia MS, Hepel J, Chung C, Contessa J, McTyre E, Peiffer AM, Lucas JT Jr, Isom S, Pajewski NM, Kotecha R, Stavas MJ, Page BR, Kleinberg L, Shen C, Taylor RB, Onyeuku NE, Hyde AT, Gorovets D, Chao ST, Corso C, Ruiz J, Watabe K, Tatter SB, Zadeh G, Chiang VLS, Fiveash JB, Chan MD.

J Neurooncol. 2017 Nov;135(2):403-411. doi: 10.1007/s11060-017-2588-4. Epub 2017 Aug 21.

46.

Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas.

Agnihotri S, Suppiah S, Tonge PD, Jalali S, Danesh A, Bruce JP, Mamatjan Y, Klironomos G, Gonen L, Au K, Mansouri S, Karimi S, Sahm F, von Deimling A, Taylor MD, Laperriere NJ, Pugh TJ, Aldape KD, Zadeh G.

Nat Commun. 2017 Aug 4;8(1):186. doi: 10.1038/s41467-017-00174-7.

47.

Management of multiple meningiomas.

Tsermoulas G, Turel MK, Wilcox JT, Shultz D, Farb R, Zadeh G, Bernstein M.

J Neurosurg. 2018 May;128(5):1403-1409. doi: 10.3171/2017.2.JNS162608. Epub 2017 Jul 21.

PMID:
28731398
48.

Preferences and Utilities for Health States after Treatment of Olfactory Groove Meningioma: Endoscopic versus Open.

Yao CM, Kahane A, Monteiro E, Gentili F, Zadeh G, de Almeida JR.

J Neurol Surg B Skull Base. 2017 Aug;78(4):315-323. doi: 10.1055/s-0037-1598197. Epub 2017 Feb 17.

49.

Management of peripheral nerve sheath tumors: 17 years of experience at Toronto Western Hospital.

Guha D, Davidson B, Nadi M, Alotaibi NM, Fehlings MG, Gentili F, Valiante TA, Tator CH, Tymianski M, Guha A, Zadeh G.

J Neurosurg. 2018 Apr;128(4):1226-1234. doi: 10.3171/2017.1.JNS162292. Epub 2017 Jul 7.

PMID:
28686119
50.

PET imaging in patients with meningioma-report of the RANO/PET Group.

Galldiks N, Albert NL, Sommerauer M, Grosu AL, Ganswindt U, Law I, Preusser M, Le Rhun E, Vogelbaum MA, Zadeh G, Dhermain F, Weller M, Langen KJ, Tonn JC.

Neuro Oncol. 2017 Nov 29;19(12):1576-1587. doi: 10.1093/neuonc/nox112. Review.

Supplemental Content

Support Center